Varian Medical Systems (VAR) 94.60 $VAR Varian Medical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Varian Medical Systems (VAR) 94.60 $VAR

Varian Medical Systems to Hold Investor Meeting at ASTRO in Boston
PR Newswire - Wed Aug 03, 7:00AM CDT
Varian Medical Systems (NYSE: VAR) will hold a meeting for investors on Tuesday, Sept. 27, 2016, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston.
VAR: 94.60 (+0.14)

Varian Creates Interactive Online Group for Sharing Knowledge-Based RapidPlan Cancer Treatment Models
PR Newswire - Mon Aug 01, 7:15AM CDT
Varian Medical Systems (NYSE: VAR) today announced the creation of an interactive online group in which clinicians can share RapidPlan(TM) models for treating cancer patients using radiotherapy or radiosurgery. Hosted on the OncoPeer(TM) Cloud Community, the RapidPlan Model Sharing group www.oncopeer.com is open to Varian customers, and allows clinicians to share RapidPlan models that can improve the efficiency and quality of treatment models and cancer care across multiple institutions.
VAR: 94.60 (+0.14)

Varian Medical Systems Selected to Supply First Modern Radiotherapy Systems in Ethiopia
PR Newswire - Mon Aug 01, 7:00AM CDT
Cancer patients in Ethiopia will gain access to modern radiotherapy treatments for the first time with the announcement that Varian Medical Systems (NYSE: VAR) has been selected to supply advanced medical linear accelerators to six hospitals in the country. The Clinac(TM) iX treatment systems will be the first such devices offering treatments to cancer patients in a country of more than 90 million people.
VAR: 94.60 (+0.14), MDSY: 1.47 (unch)

Watch for Varian Medical Systems to Potentially Pullback After Gaining 6.22% Yesterday
Comtex SmarTrend(R) - Thu Jul 28, 1:01PM CDT
Varian Medical Systems (NYSE:VAR) traded in a range yesterday that spanned from a low of $90.10 to a high of $94.16. Yesterday, the shares gained 6.2%, which took the trading range above the 3-day high of $88.91 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VAR: 94.60 (+0.14)

Varian Medical (VAR) Beats Q3 Earnings & Sales; View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:15AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.22 per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a nickel.
BABY: 38.41 (-0.04), ABMD: 118.79 (-0.12), MASI: 52.64 (+0.10), VAR: 94.60 (+0.14)

Varian Chosen to Equip First Government Owned Proton Center in China
PR Newswire - Wed Jul 27, 3:15PM CDT
Varian Medical Systems (NYSE: VAR), today announced it has been selected to install and service its ProBeam® proton therapy system in the new multi-room Hefei Ion Medical Center (HIMC) being built in Hefei, Anhui Province, China. The company booked the order for the equipment as well as its ARIA® information management and Eclipse(TM) treatment planning software in the third quarter of its fiscal year 2016.
VAR: 94.60 (+0.14)

Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016
PR Newswire - Wed Jul 27, 3:05PM CDT
Varian Medical Systems (NYSE: VAR) today is reporting GAAP net earnings of $1.04 per diluted share and non-GAAP net earnings of $1.22 per diluted share for the third quarter of fiscal year 2016. Varian's revenues totaled $789 million for the third quarter, up 1 percent from the year-ago quarter in dollars and even with the year-ago quarter in constant currency. The company ended the quarter with a $3.3 billion backlog, up 5 percent from the end of the third quarter of fiscal year 2015.
VAR: 94.60 (+0.14)

Varian Medical: Claymount Collimators Get FDA Registration
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 7:31AM CDT
Varian Medical Systems, Inc. recently received the U.S. Food and Drug Administration (FDA) registration for its Claymount Optica 20 and Optica 40 collimators.
MASI: 52.64 (+0.10), VAR: 94.60 (+0.14), MLAB: 105.11 (-3.16), NVDQ: 10.64 (+0.06)

Varian Medical Systems Receives FDA Registration for Claymount Optica Collimators
PR Newswire - Mon Jul 18, 7:15AM CDT
Varian Medical Systems (NYSE: VAR) today announced it has received U.S. Food and Drug Administration (FDA) registration for its Claymount Optica 20 and Optica 40 collimators. Claymount's Optica collimators are used to narrow the focus of X-ray beams in film-based and digital radiography systems for improving image quality and minimizing dose to patients.
VAR: 94.60 (+0.14)

What Investors are Making of These Medical Appliances and Equipment Stocks? - St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Thu Jul 07, 6:40AM CDT
Stock-Callers.com's focus this morning is on the Medical Appliances and Equipment industry, which can expect strong growth for the remainder of this year despite headwinds. We look at the featured companies for today and review their recent performances: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks and receive your complimentary notes at:
VAR: 94.60 (+0.14), STE: 70.48 (-0.28), RMD: 68.88 (-0.50), STJ: 83.50 (-0.02), MDSY: 1.47 (unch)

Varian Medical Systems (VAR) Approaches New Upside Target of $82.48
Comtex SmarTrend(R) - Tue Jun 21, 8:46AM CDT
Varian Medical Systems (NYSE:VAR) has opened bullishly above the pivot of $81.83 today and has reached the first level of resistance at $82.07. Analysts will be watching for a cross of the next upside pivot targets of $82.48 and $83.13.
VAR: 94.60 (+0.14)

Varian Medical Systems Holding Investor Meeting Today
PR Newswire - Tue Jun 21, 7:00AM CDT
Varian Medical Systems (NYSE: VAR) announced it is hosting an investor day at its headquarters in Palo Alto, Calif., today, Tuesday, June 21. The company's corporate and business management will discuss global growth strategies in its Oncology Systems, Imaging Components and Particle Therapy businesses. Presentations will focus on emerging technologies, product portfolios, and market trends that will support the expansion of Varian's businesses.
VAR: 94.60 (+0.14)

Varian Medical Systems Launches Proton Therapy Blog
PR Newswire - Mon Jun 20, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced the launch of Spot ON, a company blog about proton therapy for the treatment of cancer. Targeted at clinicians, physicists and administrators of radiotherapy centers around the world, Spot ON will deliver information about new technology developments, system deployments, research and insights from clinicians.
VAR: 94.60 (+0.14)

Varian Medical Clinches TrueBeam System Order in Australia
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 6:47AM CDT
Varian Medical Systems Inc. (VAR) won order from Australia-based Icon Group to supply 10 additional TrueBeam medical linear accelerators.
IRMD: 17.22 (+0.15), MASI: 52.64 (+0.10), VAR: 94.60 (+0.14), CRY: 14.13 (-0.12)

Icon Group in Australia Selects Varian Advanced Radiotherapy Equipment
PR Newswire - Thu Jun 16, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced it has been selected by the Icon Group to provide 10 TrueBeam® medical linear accelerators for cancer centers Icon operates across Australia. Varian will install the TrueBeam systems in the Icon centers over the next two years and continue to service them under a multi-year agreement.
VAR: 94.60 (+0.14)

Varian and Russian Proton Therapy Center Achieve Milestone with Cyclotron Installation
PR Newswire - Thu Jun 09, 7:00AM CDT
Russia's first dedicated proton therapy treatment center achieved a major milestone this week with the installation of the cyclotron by equipment supplier Varian Medical Systems (NYSE: VAR). The installation, a key milestone for each new proton therapy center, involved the cyclotron being lifted into position by cranes in a procedure that was watched by local government officials including the governor of St. Petersburg.
VAR: 94.60 (+0.14)

Varian Keeps Up the Winning Streak in Turkey, Expands Base
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:39AM CDT
Varian Medical Systems Inc (VAR) is on a roll, winning a string of orders in Turkey.
IRMD: 17.22 (+0.15), MASI: 52.64 (+0.10), VAR: 94.60 (+0.14), CRY: 14.13 (-0.12)

Varian to Showcase Imaging Solutions At 19th World Conference On Non-destructive Testing
PR Newswire - Wed Jun 08, 7:15AM CDT
Varian Medical Systems (NYSE: VAR), today announced plans to demonstrate its security and industrial imaging solutions June 13-17 in Munich Germany at the 19th World Conference on Non-destructive Testing (WCNDT), booth FE73.
VAR: 94.60 (+0.14), MDSY: 1.47 (unch)

Varian Extending Advanced Cancer Care in Turkey
PR Newswire - Tue Jun 07, 7:00AM CDT
Cancer patients in Turkey will gain access to advanced radiotherapy treatments with news that Varian Medical Systems (NYSE: VAR), world leader in radiotherapy and radiosurgery, has been selected to supply multiple treatment machines to public and private hospitals in the country. To date this year, Varian has booked orders for more than 20 medical linear accelerators from Turkish hospitals. The new systems will be delivered over the next 18 months.
VAR: 94.60 (+0.14), MDSY: 1.47 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 43

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 49

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 87

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 12

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 34

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 55

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 54

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 31

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Challenge: Investors Pursue Justice Against TLX

Updated Category News Views 164

Opportunity for Investors in Telix Pharmaceuticals Ltd. Attention, investors! A significant event has unfolded for those who have purchased securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). The Rosen Law Firm, well-known for representing investors' rights, has initiated a class action lawsuit on behalf of these investors. This development presents a chance for you...

Continue Reading
Turvo and SMC3 Forge Alliance to Enhance Freight Efficiency

Updated Category News Views 158

Strategic Partnership Between Turvo and SMC3 Industry leaders are joining forces to enhance freight management solutions, facilitated by insights from a global logistics company. Turvo, known for its collaborative application tailored for the supply chain, has announced an integration partnership with SMC3, a respected provider of less-than-truckload (LTL) freight...

Continue Reading
Fnac Darty Takes Major Steps in Unieuro Acquisition Process

Updated Category News Views 148

Fnac Darty Makes Progress in Unieuro Acquisition Fnac Darty has recently announced significant developments regarding its acquisition of Unieuro. The authorization to officially notify this transaction was granted by the European Commission, following a pre-notification phase that lasted several months. This is an exciting development for shareholders and has set the...

Continue Reading
LOGISTEC Appoints Cleidy Liborio Fernandes as CCO for Growth

Updated Category News Views 202

CLEIDY LIBORIO FERNANDES JOINS LOGISTEC AS CHIEF COMMERCIAL OFFICER LOGISTEC, a prominent provider of marine and environmental services in North America, is delighted to announce the appointment of Cleidy Liborio Fernandes as the new Chief Commercial Officer. Cleidy's extensive background in international business and strategic development is expected to spearhead the...

Continue Reading
IMUNON Inc's Latest Developments Drive Stock Surge Today

Updated Category News Views 233

IMUNON Inc's Stock Surge Explained Shares of IMUNON Inc (NASDAQ: IMNN) are seeing a remarkable uptick in trading this Wednesday. The excitement is largely due to the company achieving a significant clinical milestone for its lead drug candidate, IMNN-001. This news has generated substantial interest among investors and highlights IMUNON's progress in the pharmaceutical...

Continue Reading